Have we found the right patient population for transplantation in follicular lymphoma?

Have we found the right patient population for transplantation in follicular lymphoma?
复制标题

我们是否找到了适合滤泡性淋巴瘤移植的患者群体?

DOI:
10.1002/cncr.31376
复制
发表时间:
2018
期刊:
影响因子:
6.2
通讯作者:
Gopal,AjayK
Gopal,AjayK
中科院分区:
医学1区
文献类型:
--
作者:
Lynch,RyanC;Gopal,AjayK

文献摘要

相似文献

前瞻性、多中心随机 GITMO/IIL 试验比较了诊断时高危滤泡性淋巴瘤的强化 (R-HDS) 与常规 (CHOP-R) 化学免疫疗法:R-HDS 的卓越疾病控制并不转化为总体生存优势。
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.